Acrivon Therapeutics, Inc. Common Stock
ACRV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,034 | $109 | $253 | $347 |
| - Cash | $40 | $36 | $30 | $100 |
| + Debt | $4 | $5 | $5 | $6 |
| Enterprise Value | $1,998 | $77 | $228 | $253 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$1 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$80 | -$60 | -$32 | -$16 |
| % Margin | – | – | – | – |
| Net Income | -$81 | -$60 | -$31 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.1 | -2.74 | -1.42 | -1.26 |
| % Growth | 23.4% | -93% | -12.7% | – |
| Operating Cash Flow | -$66 | -$43 | -$30 | -$14 |
| Capital Expenditures | -$3 | -$1 | -$2 | -$0 |
| Free Cash Flow | -$68 | -$44 | -$32 | -$14 |